Clinical Trial Update: Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy

View source ↗

Summary

This clinical trial update describes the systematic assessment of hereditary pancreatic cancer risk and its implications for personalized therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer | Status: ACTIVE_NOT_RECRUITING